TNYA logo

TNYA
Tenaya Therapeutics Inc

2,205
Mkt Cap
$175.36M
Volume
2.36M
52W High
$2.35
52W Low
$0.3901
PE Ratio
-1.71
TNYA Fundamentals
Price
$0.79
Prev Close
$0.8081
Open
$0.80
50D MA
$0.7701
Beta
2.33
Avg. Volume
3.09M
EPS (Annual)
-$0.5923
P/B
1.65
Rev/Employee
$0.00
$19.12
Loading...
Loading...
News
all
press releases
Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates
Tenaya Therapeutics (TNYA) delivered earnings and revenue surprises of +4.26% and -97.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
More News
News Placeholder
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Rating of "Moderate Buy" by Analysts
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the company, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Shares Down 5% - Here's What Happened
Tenaya Therapeutics (NASDAQ:TNYA) Shares Down 5% - What's Next...
MarketBeat·1mo ago
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen cut shares of Tenaya Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·2mo ago
News Placeholder
Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA)
Chardan Capital reiterated a "buy" rating and set a $8.00 price target on shares of Tenaya Therapeutics in a research report on Thursday...
MarketBeat·2mo ago
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Issues Earnings Results, Meets Expectations
Tenaya Therapeutics (NASDAQ:TNYA - Get Free Report) released its earnings results on Wednesday. The company reported ($0.12) earnings per share for the quarter, hitting analysts' consensus estimates...
MarketBeat·2mo ago
News Placeholder
Lifesci Capital Upgrades Tenaya Therapeutics (NASDAQ:TNYA) to Strong-Buy
Lifesci Capital raised shares of Tenaya Therapeutics to a "strong-buy" rating in a report on Thursday...
MarketBeat·3mo ago
News Placeholder
TNYA Pulls Back After Hours Following Significant $1.13B Deal-Spurred Rally
Tenaya shares closed 40% higher in the regular trading session after it entered into a research collaboration deal with Alnylam Pharmaceuticals.
Stocktwits·3mo ago
News Placeholder
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Tenaya Therapeutics stock jumps after announcing a research collaboration with Alnylam worth up to $1.13 billion in milestone payments.read more...
Benzinga·3mo ago
News Placeholder
Tenaya Therapeutics (TNYA) Projected to Post Earnings on Monday
Tenaya Therapeutics (NASDAQ:TNYA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 9. (View Earnings Report at...
MarketBeat·3mo ago
<
1
2
...
>

Latest TNYA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.